Last reviewed · How we verify
NCT07165561
Evaluation of an App for Young People With Suicidal Thoughts
NA trial testing Smartphone App in Suicidal Behavior in 80 participants. Currently enrolling.
1 February 2026
Quick facts
| Lead sponsor | University Ghent |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 80 |
| Start date | 12 September 2025 |
| Primary completion | 1 February 2026 |
| Estimated completion | 1 April 2026 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Smartphone App
Conditions studied
- Suicidal Behavior — all drugs for Suicidal Behavior →
- Suicidal Ideation — all drugs for Suicidal Ideation →
- Coping Behavior — all drugs for Coping Behavior →
Sponsor
University Ghent
Who can join
Adults 12 to 17, any sex, with Suicidal Behavior or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are currently very few evidence-based tools specifically designed to support children and adolescents experiencing suicidal thoughts. Digital interventions are increasingly used in suicide prevention and show promise in helping young people improve emotional regulation, coping skills, and manage suicidal thoughts and behaviors. In Flanders, the app BackUp was developed in 2015 by VLESP to support adults with suicidal thoughts. Research showed that while the app led to a small, non-significant reduction in suicidal thoughts after one week, 70% of users found it helpful in daily life. A key feature of the app is the Safety Plan, based on cognitive behavioral therapy, which helps individuals identify coping strategies and sources of support. This approach has proven effective in reducing suicidal behavior and is also suitable for use with children and adolescents. Despite these developments, there is still a need for a digital tool specifically tailored to young people. In 2023, the investigators launched a project to develop a new app in collaboration with youth care professionals, app developers, and adolescents with lived experience of suicidality. Their input ensures the app meets the needs and preferences of young users. This study aims to evaluate the effectiveness and usability of the app through a pilot study involving adolescents aged 12-17 who are currently experiencing suicidal thoughts. Participants and their parents or guardians must provide informed consent before joining the study. The evaluation includes online questionnaires completed before and after using the app. These questionnaires collect information on demographics, coping strategies, and the severity of suicidal thoughts and behaviors. The post-assessment also includes questions about user experience and satisfaction. No interviews are conducted; all data are collected digitally. Participants are recruited through various channels and must meet specific inclusion criteria. After completing the initial questionnaire, they receive a code to access the app, ensuring that only study participants can use it.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07165561
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Smartphone App
Trials testing the same drug.
- NCT05785533 — A Mobile Recovery Guidance App for Children and Young Adults With Acute Ankle Inversion Injuries · NA · recruiting
- NCT06114199 — Enhancing the Effectiveness of Home-delivery Based Produce Prescription Program Implementation Strategies · NA · recruiting
- NCT06923033 — Aim 1: App for Reducing Cravings to Smoke · NA · completed
- NCT04896593 — Mobile Technology for Reducing and Preventing Adolescent Suicide · NA · completed
- NCT04046497 — Artificial Intelligence to Measure Adherence to Oral Medication · Phase 4 · recruiting
Other recruiting trials for Suicidal Behavior
Currently open trials in the same condition.
- NCT06701006 — Integrated Suicide Supports and Safety Planning for Youth · NA · recruiting
- NCT07294001 — Shame-Focused Cognitive Behavioral Therapy For Reducing Suicide Risk In Adolescent Psychiatric Inpatients (SF-CBT) · NA · recruiting
- NCT07303959 — Sleep Treatment for Teens (RCT Phase) · NA · recruiting
- NCT05409794 — Basal Plasma Lithium Levels and Suicidal Events · recruiting
- NCT03185026 — Psychoeducation for Suicidal Behavior · NA · recruiting
Other University Ghent trials
Trials by the same sponsor.
- NCT07398053 — General Practitioner & Pharmacist Support for Discontinuing Long-term Antidepressants in Clinically Stable Patients · NA · not yet recruiting
- NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
- NCT07091071 — Evaluation of the CochSyn Device in Clinical Practice · NA · completed
- NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
- NCT07176156 — Evaluation of the Quality of Chat Conversations With the Suicide Helpline Zelfmoordlijn 1813 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07165561 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Ghent
- Last refreshed: 17 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07165561.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing